APGE
Apogee Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Apogee Therapeutics (APGE) Stock: Buy, Sell, or Hold?
$135.07
-0.01 (-0.01%)
▼
5d:
+0.09%
30d:
+0.66%
90d:
+60.43%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Aug 10, 2026
0d
Protect APGE Gains
Updated Sep 2, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (64%)
Quality Score
54/100
Position
FAIR
Forward P/E & Valuation
-25.8x
Next 12M consensus est.
Wall Street Target
$134.85
-0.2% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$134.68 / $135.09
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: APGE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $135.07, which is considered fair based on recent price action.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
54/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$134.68
Resistance Level
$135.09
Current Trend
Strong Uptrend
Technical data as of
Sep 2, 2026
Protect Your Profits
APGE is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- NEUTRAL: Near Wall St target ($134.85)
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-25.81
Wall Street Target
$134.85
(-0.2%)
Share APGE Analysis
Share this live APGE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (APGE)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 2, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages suggest a bullish outlook on $APGE, with one user noting past instances of rising short interest before biotech company buyouts.
Key Retail Themes:
short interest
biotech company buyouts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 36 SELL |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive APGE Research Pages
